Therapeutic Asset Ratings

2,273 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
NORMAL HUMAN SERUM ALBUMIN Female Reproductive Organ Cancer	Joachim Zdolsek	P4	B (62)
Oxodotreotide Metastatic Malignant Neoplasm in the Liver	Vanderbilt-Ingram Cancer Center	P4	B (62)
Semaglutide Bipolar I Disorder	Mayo Clinic	P4	B (62)
Semaglutide Bipolar II Disorder	Mayo Clinic	P4	B (62)
ANTIHEMOPHILIC FACTOR,HUMAN,METHOD M,MONOCLONAL Hemophilia A	Dhaka Medical College	P3	B (62)
ASPARAGINASE Myelodysplastic Syndrome	Children's Oncology Group	P3	B (62)
Cagrilintide Type 2 Diabetes Mellitus	Novo Nordisk A/S	P3	B (62)
Degarelix Castration-resistant Prostate Cancer	Bayer	P3	B (62)
FIBROMUN Melanoma	Philogen S.p.A.	P3	B (62)
FILGRASTIM Glioblastoma	Massachusetts General Hospital	P3	B (62)
FILGRASTIM Lung Cancer	University of Washington	P3	B (62)
FILGRASTIM Myelofibrosis	City of Hope Medical Center	P3	B (62)
GELATIN PORCINE SKIN, FORMALIN TREATED Carcinoma, Hepatocellular	Teclison Ltd.	P3	B (62)
IMMUNOTHERAPIC BIFUNCTIONAL FUSION PROTEIN COMPRISED OF A FULLY HUMAN IGG1 MONOCLONAL ANTIBODY (AVELUMAB) AGAINST HUMAN PROGRAMMED DEATH-LIGAND 1 (PD-L1) FUSED TO THE SOLUBLE EXTRACELLULAR DOMAIN OF TRANSFORMING GROWTH FACTOR-.BETA. (TGF-.BETA.) RECEPTOR II, WHICH ACTS AS A TGF-.BETA. TRAP Stage IIIA Lung Cancer AJCC v8	EMD Serono Research & Development Institute, Inc.	P3	B (62)
NORMAL HUMAN SERUM ALBUMIN Acute Kidney Injury	Institute of Liver and Biliary Sciences, India	P3	B (62)
PENTAPEPTIDE-1 Hepatocellular Carcinoma	Second Affiliated Hospital of Soochow University	P3	B (62)
Retatrutide Osteoarthritis, Knee	Eli Lilly and Company	P3	B (62)
Semaglutide Weight, Body	Loma Linda University	P3	B (62)
Tenecteplase Endovascular Treatment	Beijing Tiantan Hospital	P3	B (62)
.ALPHA.-1 PROTEASE INHIBITOR Pulmonary Emphysema	Sanofi	P2	B (62)
CYCLOSPORIN A Sickle Cell Disease	City of Hope Medical Center	P2	B (62)
FILGRASTIM Beta-Thalassemia	National Heart, Lung, and Blood Institute (NHLBI)	P2	B (62)
FILGRASTIM Hematologic Malignancy	St. Jude Children's Research Hospital	P2	B (62)
FILGRASTIM Severe Aplastic Anemia	Masonic Cancer Center, University of Minnesota	P2	B (62)
Aldafermin Primary Sclerosing Cholangitis	NGM Biopharmaceuticals, Inc	P2/3	B (62)

Showing 526 to 550 of 2,273 assets

PreviousPage 22 of 91Next